Team:UQ-Australia

From 2011.igem.org

(Difference between revisions)
 
(5 intermediate revisions not shown)
Line 2: Line 2:
{|style="width:100%;" border="0" cellpadding="10" cellspacing="0"  
{|style="width:100%;" border="0" cellpadding="10" cellspacing="0"  
|rowspan="2"|The human circadian rhythm drives many important processes in the body in accordance with the sleep/wake cycle. A characteristic of this biological clock is the periodic oscillation of gene expression. Current parts in the Registry designed to regulate periodic oscillations of gene expression have shown limited success.
|rowspan="2"|The human circadian rhythm drives many important processes in the body in accordance with the sleep/wake cycle. A characteristic of this biological clock is the periodic oscillation of gene expression. Current parts in the Registry designed to regulate periodic oscillations of gene expression have shown limited success.
-
Here we demonstrate a biological clock being standardised as a set of BioBrick parts.
+
Here we demonstrate the feasibility a biological clock being standardised as a set of BioBrick parts.
Our network is controlled by an engineered promoter, Plac/ara, which features both an activator and a repressor domain. This controls the production of downstream genes to activate other inducible promoters, pBAD and GlnAp2, eventually leading to the production of a repressor protein, lacI, which inhibits Plac/ara, resulting in oscillatory expression. This project shows the feasibility of standardising the biological clock in E. coli and grounds further development for applications in regulated drug/hormone delivery and ion channel control.
Our network is controlled by an engineered promoter, Plac/ara, which features both an activator and a repressor domain. This controls the production of downstream genes to activate other inducible promoters, pBAD and GlnAp2, eventually leading to the production of a repressor protein, lacI, which inhibits Plac/ara, resulting in oscillatory expression. This project shows the feasibility of standardising the biological clock in E. coli and grounds further development for applications in regulated drug/hormone delivery and ion channel control.
-
'''Find us on [http://www.facebook.com/pages/UQ-iGEM-2011/174356539258535 Facebook]!'''
+
[[File:Logo facebook.jpg|200px|link=http://www.facebook.com/UQiGEM.2011]]
-
 
+
-
'''NB: wiki best viewed on Chrome, Firefox or Safari.'''
+
! width="125" |[[File:IGEM basic Logo stylized.png|125x125px|link=https://2011.igem.org]]
! width="125" |[[File:IGEM basic Logo stylized.png|125x125px|link=https://2011.igem.org]]
|-
|-
|[[File:UQ-Australia_logo_2011.png|125x125px|link=https://2011.igem.org/Team:UQ-Australia]]
|[[File:UQ-Australia_logo_2011.png|125x125px|link=https://2011.igem.org/Team:UQ-Australia]]
|}
|}
 +
 +
 +
'''NB: wiki best viewed on Chrome, Firefox or Safari.'''

Latest revision as of 00:32, 6 October 2011




The human circadian rhythm drives many important processes in the body in accordance with the sleep/wake cycle. A characteristic of this biological clock is the periodic oscillation of gene expression. Current parts in the Registry designed to regulate periodic oscillations of gene expression have shown limited success.

Here we demonstrate the feasibility a biological clock being standardised as a set of BioBrick parts.

Our network is controlled by an engineered promoter, Plac/ara, which features both an activator and a repressor domain. This controls the production of downstream genes to activate other inducible promoters, pBAD and GlnAp2, eventually leading to the production of a repressor protein, lacI, which inhibits Plac/ara, resulting in oscillatory expression. This project shows the feasibility of standardising the biological clock in E. coli and grounds further development for applications in regulated drug/hormone delivery and ion channel control.

Logo facebook.jpg

IGEM basic Logo stylized.png
UQ-Australia logo 2011.png


NB: wiki best viewed on Chrome, Firefox or Safari.

Retrieved from "http://2011.igem.org/Team:UQ-Australia"